Stocks · Health care · Services-Offices & Clinics of Doctors of Medicine

Starling Oncology, Inc.

STLN Clue Score47
United States Fiscal year ends December CIK 0001799191 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Yale Podnos
14 Jul 2026
Chief Medical Officer
Sold after exercise
5,478
$6.35
$34.79K
Yale Podnos
14 Jul 2026
Chief Medical Officer
Sold after exercise
17,974
$6.43
$115.55K
Brad Hively
3 Jun 2025
Director
Sold after exercise
108,532
$2.87
$311.52K
Brad Hively
3 Jun 2025
Director
Sold after exercise
1,867,605
$2.87
$5.36M
Brad Hively
17 Nov 2023
Director
Sold after exercise
25,000
$2.24
$56.00K
Brad Hively
13 Nov 2023
Director
Sold after exercise
47,000
$2.52
$118.58K

What was left out

Form 4 filings counted 216
Amendments (4/A) skipped 17
Filings about a different issuer 0
Unreadable filings 0
Joint filings 37
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 6
Sales at will 84
Transactions with no price 0
Shares from compensation/vesting 52,634,347
Sales filed before the plan box existed 65
History held since 17 Mar 2020